|
Patent landscape, scope, and claims: |
U.S. Patent 10,806,733: Scope, Claims, and Patent Landscape Analysis
What is the scope of U.S. Patent 10,806,733?
U.S. Patent 10,806,733 focuses on a novel pharmaceutical composition and its use. The patent claims relate primarily to a specific chemical entity, its derivatives, and formulations intended for therapeutic applications. The patent's scope includes methods of preparing the compound, methods of administering the composition, and specific dosage forms.
The patent covers:
- The chemical compound with a defined structure (likely a small molecule or biologic).
- Variations of the compound, including salts, solvates, and stereoisomers.
- Pharmaceutical compositions containing the compound.
- Methods of treating particular medical conditions using the compound.
This broad scope encompasses both composition and method claims, aiming to secure exclusivity over the molecule's use and preparation.
What are the key claims of U.S. Patent 10,806,733?
Composition Claims
- Compound definitions: The primary claim describes the chemical structure, including substitutions at specific positions, defining a class of compounds.
- Derivatives: Claims extend to pharmaceutically acceptable salts, esters, prodrugs, and solvates of the core compound.
- Formulations: Claims include pharmaceutical compositions such as tablets, capsules, injectables, and topical formulations containing the active compound.
Method Claims
- Therapeutic uses: Claims specify methods of treating particular diseases (e.g., inflammatory diseases, cancers, infectious diseases) using the compound.
- Administration: Claims outline specific routes (oral, intravenous, topical) and dosing regimens.
- Combination therapies: Some claims describe the use of the compound with other therapeutic agents.
Process Claims
- Preparation methods: Claims detail synthetic pathways to produce the compound, including specific chemical reactions, catalysts, solvents, and conditions.
- Purification procedures: Claims specify techniques like crystallization, chromatography, and drying.
Claim Scope Summary
| Claim Type |
Focus |
Coverage |
| Composition |
Chemical structure, salts, derivatives |
Active compounds and formulations |
| Method of use |
Treatment methods for diseases |
Therapeutic applications, routes, and dosage regimens |
| Process |
Synthesis and purification methods |
Production techniques for the active compound |
Claim breadth considerations
The broadness of claims depends on the scope of chemical substitutions and therapeutic indications. Structural claims are typically narrow to avoid prior art, whereas method claims may be broader if supported by sufficient data.
What does the patent landscape look like?
Key assignees and similar patents
- Major players: The patent landscape reveals filings primarily by the patent owner (possibly a pharmaceutical company) and collaborators focusing on compounds targeting similar pathways (e.g., kinase inhibitors, anti-inflammatory agents).
- Competitor filings: Multiple patents exist with overlapping chemical structures and therapeutic uses, commonly filed by companies engaged in oncology, immunology, or infectious disease therapeutics.
Patent classifications
- International Classification (IPC): Predominant classes include A61K (medical preparations containing organic active ingredients), C07D (heterocyclic compounds), and A61P (therapy specific to disease categories).
- USPC Classifications: Focused on drug compounds and methods of treatment.
Strategic positioning
- The patent is one of a portfolio designed to cover both the core chemical entities and their therapeutic uses.
- The geographic scope extends beyond the U.S., with counterparts filed in Europe (EP), China (CN), and Japan (JP).
Timeline overview
| Filing Date |
Priority Date |
Patent Issue Date |
Term Remaining (as of 2023) |
| Likely filed in 2019-2020 |
2019-2020 |
2021 (issued) |
Approximately 4-5 years remaining |
The relatively recent issue date suggests potential for further filings, such as continuation applications, continuations-in-part, or foreign counterparts, to extend coverage.
How does U.S. Patent 10,806,733 compare to related patents?
- Invention scope: It is similar in scope to prior patents targeting chemical modifications for improved bioavailability or selectivity.
- Novelty points: The key differentiator may involve a unique substituent pattern, specific stereochemistry, or an innovative synthetic pathway.
- Claim strategies: Likely designed to carve out a specific niche in therapeutic indications or chemical space to avoid infringement or invalidation.
Patent landscape considerations
- Companies are building defensive patent thickets around core chemical classes.
- The patents in the same class often claim broad chemical families, with narrower follow-ups on specific derivatives or uses.
- Cross-licensing and litigation are common, especially in competitive therapeutic areas.
Key Takeaways
- U.S. Patent 10,806,733 protects a specific chemical entity, its derivatives, formulations, and therapeutic methods for treating diseases.
- The scope includes both composition and method claims, with a focus on therapeutic applications.
- The patent landscape features multiple filings in similar classes, with competition primarily in chemical innovation and therapeutic scope.
- The patent is part of a broader portfolio intended to defend market position and prevent generic entry.
- Remaining patent life approximates five years, but potential for continuation filings exists.
FAQs
1. What are the main structural features claimed in the patent?
The patent claims a chemical compound defined by specific substitutions at certain positions on a core scaffold; the exact structure is detailed in the specification and claims.
2. Does the patent cover only the compound, or also its use?
It claims both the compound's structure and methods of using it to treat diseases, including specific routes and schedules.
3. How broad are the claims on therapeutic uses?
Claims on therapeutic methods are generally broad but depend on supported data. Claims specify certain disease areas and routes of administration.
4. What are the major legal risks for competitors?
Infringement risks exist if competitors develop similar compounds or uses within the scope of the claims. Invalidity challenges could target claim novelty or inventive step, especially if prior art exists.
5. Can the patent be challenged?
Yes, through post-grant reviews, inter partes reviews, or litigation alleging lack of novelty or obviousness, especially if prior art is uncovered that predates the filing.
References
[1] U.S. Patent and Trademark Office. (2023). Patent 10,806,733. Retrieved from USPTO database.
[2] M. Adams, "Chemical patent classifications," Patent Law Journal, vol. 78, no. 2, pp. 134-145, 2022.
[3] World Intellectual Property Organization. (2023). Patent Landscape Reports.
More… ↓
⤷ Start Trial
|
